Evidence map›Paper›PMID 36969258›Full record

ArticleFrontiers in immunology2023

Editorial: Termination of pro-inflammatory signaling and its dysregulation in autoimmune diseases.

René Huber, Daniela Novick, Guochang Hu

Full text readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

René HuberInstitute of Clinical Chemistry, Hannover Medical School, Hannover, Germany.
Daniela NovickDepartment of Molecular Genetics, The Weizmann Institute of Science, Rehovot, Israel.
Guochang HuDepartment of Anesthesiology, University of Illinois College of Medicine, Chicago, IL, United States.

Funding

Role Of p120 Catenin In Sepsis-Induced Lung InjuryR01HL104092 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HU, GUOCHANG · 2010 to 2020
$3.9M
Targeting the host immune response during sepsisR01HL152696 · NHLBI · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HU, GUOCHANG · 2020 to 2023
$1.8M
Role of sumoylation in vascular endothelial barrier dysfunction in sepsisR21AI152249 · NIAID · UNIVERSITY OF ILLINOIS AT CHICAGO · PI HU, GUOCHANG · 2020 to 2021
$440k
NHLBI NIH HHS R01 HL104092NHLBI NIH HHS R01 HL152696NIAID NIH HHS R21 AI152249
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autoimmune DiseasesHumansInflammationSignal Transductionautoimmunitypharmacological modulationpro-inflammatory mediatorsresolution of inflammationtermination of pro-inflammatory signaling

Identifiers

PMID36969258
PMCPMC10036856

What Socratic holds

Textfull text, public
LicenceCC BY
measurements read3
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.